Mast cell-lineage versus basophil lineage involvement in myeloproliferative and myelodysplastic syndromes: Diagnostic role of cell-immunophenotyping

Mast cells and blood basophils are distinct hemopoietic cells. They can be distinguished from each other and from all other lymphohemopoietic cells using antibodies against surface receptors or stored cytoplasmic molecules. In patients with myelodysplastic syndromes (MDS) or myeloproliferative syndromes (MPS), an elevation of metachromatically granulated cells (MCS) is frequently seen. These cells can be classified as basophils or mast cells using monoclonal antibodies (mAbs) against leuko cyte antigens, including mast cell tryptase, c-kit (= mast cell growth factor [MGF] receptor), interleukin-3 receptor alpha chain (IL-3R alpha = CD123), and CD11b (C3biR). In a stable phase of MDS or MPS, the circulating MCS usually are basophils (histamine(+), tryptase(-), c-kit(-), IL-3R alpha(+), CD11b(+)). In an accelerated or terminal phase of disease, however, mast cell lineage involvement and circulating mast cell precursors (histamine(+), tryptase(+), c-kit(+), IL-3R alpha(-), CD11b(-)) are found in a subset of patients. The use of mAbs against mast cell antigens and granulocyte antigens is diagnostic in these patients.